(2026). Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus. PLOS Global Public Health.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cost-effectiveness of BPaL-based and 9-month Modified All-oral Short Treatment Regimens for Rifampicin-resistant Tuberculosis in Belarus."
PLOS Global Public Health 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cost-effectiveness of BPaL-based and 9-month Modified All-oral Short Treatment Regimens for Rifampicin-resistant Tuberculosis in Belarus."
PLOS Global Public Health, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.